1st Quarter - Amendment
SQUIRE PATTON BOGGS for GENENTECH, INC.
Firm
Client
Income
$90,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report | Apr 19, 2011 | $90,000 | Replaced |
| 1st Quarter - Amendment (this page) | Apr 19, 2012 | $90,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
FY11 appropriations process - including H.R.1 and various Continuing Resolutions: FDA funding issues and drug approval/review oversight process.
Foreign entity interest: same as client
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN O'NEILL | — |
| MANNY ROSSMAN | Staff,Crane,01-04;Staff,Lott,05-06;Ofce,Whip,07-09 |
Medical/Disease Research/Clinical Labs MED
Implementation of healthcare reform law. FDA Drug Approval and appeal oversight process.
Foreign entity interest: same as client
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN O'NEILL | — |
| MANNY ROSSMAN | Staff,Crane,01-04;Staff,Lott,05-06;Ofce,Whip,07-09 |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.